HIV-1 genotypic resistance in treatment-naive subjects enrolled in an observational trial (GAIN)

被引：0
|
作者：
Becker, MI
Haubrich, R
Wesselman, CW
Garrett, L
Lee, SY
Millard, D
Baxter, JD
机构：
[1] Agouron Pharmaceut Inc, La Jolla, CA USA
[2] UCSD, San Diego, CA USA
[3] Ingenix Pharmaceut Serv, Basking Ridge, NJ USA
[4] Consolidated Lab Serv, Van Nuys, CA USA
[5] RWJ Med Sch, Camden, NJ USA
来源：
ANTIVIRAL THERAPY | 2002年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
161
引用
收藏
页码：S175 / S175
页数：1
相关论文
共 50 条
  • [41] HIV-1 Diversity and Drug Resistance in Treatment-Naive Children and Adolescents from Rio de Janeiro, Brazil
    de Azevedo, Suwellen Sardinha Dias
    Delatorre, Edson
    Gaido, Cibele Marina
    Silva-de-Jesus, Carlos
    Guimaraes, Monick Lindenmeyer
    Couto-Fernandez, Jose Carlos
    Morgado, Mariza G.
    VIRUSES-BASEL, 2022, 14 (08):
  • [42] Prevalence of transmitted HIV-1 drug resistance among treatment-naive individuals in China, 2000-2016
    Yuan, Huangbo
    Liu, Zhenqiu
    Wu, Xuefu
    Wu, Mingshan
    Fang, Qiwen
    Zhang, Xin
    Shi, Tingting
    Tully, Damien C.
    Zhang, Tiejun
    ARCHIVES OF VIROLOGY, 2021, 166 (09) : 2451 - 2460
  • [43] Transmitted HIV-1 Drug Resistance in a Treatment-Naive Cohort of Recently Infected Individuals from Chennai, India
    Nesakumar, Manohar
    Haribabu, Hemalatha
    Cheedarla, Narayanaiah
    Karunaianantham, Ramesh
    Kailasam, Nandagopal
    Sathyamurthi, Pattabiraman
    Selvachithiram, Murugesan
    Tripathy, Srikanth Prasad
    Hanna, Luke Elizabeth
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2019, 35 (08) : 775 - 779
  • [44] Epidemiology and Transmitted HIV-1 Drug Resistance among Treatment-Naive Individuals in Israel, 2010-2018
    Wagner, Tali
    Zuckerman, Neta S.
    Halperin, Tami
    Chemtob, Daniel
    Levy, Itzchak
    Elbirt, Daniel
    Shachar, Eduardo
    Olshtain-Pops, Karen
    Elinav, Hila
    Chowers, Michal
    Itsomin, Valery
    Riesenberg, Klaris
    Wax, Marina
    Shirazi, Rachel
    Gozlan, Yael
    Matus, Natasha
    Girshengorn, Shirley
    Marom, Rotem
    Mendelson, Ella
    Turner, Dan
    Mor, Orna
    VIRUSES-BASEL, 2022, 14 (01):
  • [45] Phase II study of vicriviroc versus efavirenz (both with zidovudine/lamivudine) in treatment-naive subjects with HIV-1 infection
    Landovitz, Raphael J.
    Angel, Jonathan B.
    Hoffmann, Christian
    Horst, Heinz
    Opravil, Milos
    Long, Jianmin
    Greaves, Wayne
    Faetkenheuer, Gerd
    JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (08): : 1113 - 1122
  • [46] Clonal phenotypic confirmation of genotypic V3-loop tropism prediction on a treatment-naive HIV-1 infected subject sample
    Van Baelen, K.
    Vandenbroucke, I.
    Rondelez, E.
    Van Eygen, V.
    Deloof, A.
    Vermeiren, H.
    Stuyver, L. J.
    ANTIVIRAL THERAPY, 2006, 11 (05) : S191 - S191
  • [47] Evaluation of the application of HIV-1 genotypic drug resistance in treatment-naive patients in Taiwan where single-tablet regimens are used as the first-line regimens
    Chang, S.
    Lin, P.
    Chang, S.
    Su, L.
    Su, Y.
    Liu, W.
    Hung, C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [48] Genotypic resistance and the treatment of HIV-1 infection in Espirito Santo, Brazil
    Pilcher, CD
    Perkins, MD
    Fiscus, SA
    Johnston, DM
    Dietze, R
    Duque, UH
    Zago, AM
    Assad-Antunes, F
    Eron, JJ
    JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (05): : 1259 - 1263
  • [49] Weight gain in treatment-naive HIV-1 infected patients starting abacavir/lamivudine/dolutegravir or tenofovir alafenamide/emtricitabine/bictegravir
    Calza, Leonardo
    Borderi, Marco
    Colangeli, Vincenzo
    Miani, Teresa
    Nuti, Bianca
    Bon, Isabella
    Lazzarotto, Tiziana
    Viale, Pierluigi
    AIDS, 2022, 36 (01) : 153 - 155
  • [50] Prevalence of genotypic resistance to protease and reverse transcriptase inhibitors and genetic diversity in treatment-naive (HIV1)-infected Moroccan individuals
    Bakhouch, K.
    Bensghir, R.
    Blaghen, M.
    Wakrim, L.
    JOURNAL OF CLINICAL VIROLOGY, 2009, 46 : S28 - S28
12345